Jacobs Levy Equity Management, Inc Biogen Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $23.9 Billion
- Q1 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Biogen Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 61,393 shares of BIIB stock, worth $7.85 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
61,393Holding current value
$7.85 Million% of portfolio
0.04%Shares
18 transactions
Others Institutions Holding BIIB
# of Institutions
1,022Shares Held
126MCall Options Held
2.29MPut Options Held
4.26M-
Vanguard Group Inc Valley Forge, PA17MShares$2.18 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.9MShares$2.04 Billion1.84% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.86 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$946 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.67MShares$597 Million0.13% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $18.4B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...